AdaptHealth Corp.
AHCONasdaqCIK 1725255HealthcareFiscal year ends Dec 31
Reports and events: 206 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0820:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-105912 |
| 2026-08-0420:36 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-052646 |
| 2026-08-0411:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052149 |
| 2026-07-2020:35 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-085086 |
| 2026-07-0720:45 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-26-081305 |
| 2026-07-0220:01 ET | 8-K | 1.05 Material cybersecurity incident | 0001104659-26-080297 |
| 2026-06-2220:16 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-076390 |
| 2026-06-0201:02 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-069119 |
| 2026-05-0520:21 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-030602 |
| 2026-05-0511:07 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-030120 |
| 2026-04-2820:33 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001628280-26-027965 |
| 2026-04-1312:11 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-024835 |
| 2026-03-1201:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-104757 |
| 2026-02-2422:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-011213 |
| 2026-02-2412:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-010872 |
| 2025-11-0421:55 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-048944 |
| 2025-11-0412:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-048527 |
| 2025-08-0521:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037931 |
| 2025-08-0511:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-037598 |
| 2025-08-0511:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-073912 |
| 2025-06-3020:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-064140 |
| 2025-06-2021:23 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001628280-25-032464 |
| 2025-06-2020:18 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-061172 |
| 2025-05-0620:29 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-022716 |
| 2025-05-0611:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022394 |
| 2025-04-3015:55 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001628280-25-020890 |
| 2025-02-2521:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-007740 |
| 2025-02-2512:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-007553 |
| 2024-12-1316:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-128292 |
| 2024-11-0522:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045365 |
| 2024-11-0512:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045113 |
| 2024-10-3021:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-112672 |
| 2024-10-2210:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-110349 |
| 2024-09-3020:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-104290 |
| 2024-09-1612:39 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-100033 |
| 2024-08-2611:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-092623 |
| 2024-08-1921:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-090892 |
| 2024-08-0620:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035235 |
| 2024-08-0611:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034954 |
| 2024-07-0313:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-077607 |
| 2024-06-2120:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001104659-24-073974 |
| 2024-06-1120:14 ET | SC 13D/A | Ownership report, active investor, amended | 0001062993-24-012367 |
| 2024-05-0721:23 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021191 |
| 2024-05-0711:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-020835 |
| 2024-04-2620:31 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001104659-24-052998 |
| 2024-04-1720:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-048318 |
| 2024-03-0421:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-030510 |
| 2024-02-2721:33 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-007254 |
| 2024-02-2712:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-007032 |
| 2023-12-2721:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-129725 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.